200 related articles for article (PubMed ID: 8662882)
1. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
[TBL] [Abstract][Full Text] [Related]
2. Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein.
Sticht H; Auer M; Schmitt B; Besemer J; Horcher M; Kirsch T; Lindley IJ; Rösch P
Eur J Biochem; 1996 Jan; 235(1-2):26-35. PubMed ID: 8631339
[TBL] [Abstract][Full Text] [Related]
3. A mutant of melanoma growth stimulating activity does not activate neutrophils but blocks erythrocyte invasion by malaria.
Hesselgesser J; Chitnis CE; Miller LH; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth C; Gillece-Castro BL; Horuk R
J Biol Chem; 1995 May; 270(19):11472-6. PubMed ID: 7744785
[TBL] [Abstract][Full Text] [Related]
4. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
Schraufstätter IU; Barritt DS; Ma M; Oades ZG; Cochrane CG
J Immunol; 1993 Dec; 151(11):6418-28. PubMed ID: 8245475
[TBL] [Abstract][Full Text] [Related]
5. Characterization of two high affinity human interleukin-8 receptors.
Lee J; Horuk R; Rice GC; Bennett GL; Camerato T; Wood WI
J Biol Chem; 1992 Aug; 267(23):16283-7. PubMed ID: 1379593
[TBL] [Abstract][Full Text] [Related]
6. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells.
Mueller SG; Schraw WP; Richmond A
J Biol Chem; 1994 Jan; 269(3):1973-80. PubMed ID: 8294449
[TBL] [Abstract][Full Text] [Related]
7. Purification, receptor binding analysis, and biological characterization of human melanoma growth stimulating activity (MGSA). Evidence for a novel MGSA receptor.
Horuk R; Yansura DG; Reilly D; Spencer S; Bourell J; Henzel W; Rice G; Unemori E
J Biol Chem; 1993 Jan; 268(1):541-6. PubMed ID: 8380167
[TBL] [Abstract][Full Text] [Related]
8. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
[TBL] [Abstract][Full Text] [Related]
9. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
[TBL] [Abstract][Full Text] [Related]
10. The orphan mouse receptor interleukin (IL)-8R beta binds N51. Structure-function analysis using N51/IL-8 chimeric molecules.
Heinrich JN; Bravo R
J Biol Chem; 1995 Mar; 270(10):4987-9. PubMed ID: 7890604
[TBL] [Abstract][Full Text] [Related]
11. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
Ahuja SK; Lee JC; Murphy PM
J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
[TBL] [Abstract][Full Text] [Related]
13. N51 competes 125I-interleukin (IL)-8 binding to IL-8R beta but not IL-8R alpha. Structure-function analysis using N51/IL-8 chimeric molecules.
Heinrich JN; Bravo R
J Biol Chem; 1995 Nov; 270(47):28014-7. PubMed ID: 7499284
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.
Heinrich JN; O'Rourke EC; Chen L; Gray H; Dorfman KS; Bravo R
Mol Cell Biol; 1994 May; 14(5):2849-61. PubMed ID: 8164648
[TBL] [Abstract][Full Text] [Related]
15. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions.
Gayle RB; Sleath PR; Srinivason S; Birks CW; Weerawarna KS; Cerretti DP; Kozlosky CJ; Nelson N; Vanden Bos T; Beckmann MP
J Biol Chem; 1993 Apr; 268(10):7283-9. PubMed ID: 8463264
[TBL] [Abstract][Full Text] [Related]
16. The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8.
Suzuki H; Prado GN; Wilkinson N; Navarro J
J Biol Chem; 1994 Jul; 269(28):18263-6. PubMed ID: 7518426
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor.
Chaudhuri A; Zbrzezna V; Polyakova J; Pogo AO; Hesselgesser J; Horuk R
J Biol Chem; 1994 Mar; 269(11):7835-8. PubMed ID: 8132497
[TBL] [Abstract][Full Text] [Related]
18. Discrete steps in binding and signaling of interleukin-8 with its receptor.
Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
[TBL] [Abstract][Full Text] [Related]
19. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
